Cover Image
Market Research Report

North America Intragastric Balloon Market Forecast 2019-2028

Published by Inkwood Research Product code 945439
Published Content info 118 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Intragastric Balloon Market Forecast 2019-2028
Published: June 30, 2020 Content info: 118 Pages
Description

KEY FINDINGS

The North America intragastric balloon market is expected to grow at a CAGR of 12.28%, throughout the forecast years of 2019 to 2028. The key factors projected to augment the market growth are the prevalence of obesity, detrimental lifestyles, and an increase in government initiatives.

MARKET INSIGHTS

Canada and the United States are evaluated in the analysis of the North America intragastric balloon growth. In Canada, one in four adults and one in ten children suffer from clinical obesity. This implies that over 6 million Canadians are obese and may need immediate assistance in controlling and managing their weight. Moreover, obesity is the foremost cause of conditions like type 2 diabetes, hypertension, strokes, arthritis, cancer, and other heart diseases, obesity impacts not only the individual but also their family, neighbors, employers, health care professionals, and governments. This occurs as a result of the effect of weight bias against people with obesity. The obesity stigma also renders into substantial inequities in professional life, health, and education often because of negative stereotypes that overweight individuals are lethargic, unmotivated, and undisciplined. Moreover, the Canadian government largely promotes physical activity, healthy eating, and maintaining healthy and adequate weight. In 2015, the country's provincial, federal, and territorial ministers of healthy living and sport, physical activity, and recreation presented e-report progress on healthy weights in Canada. The e-report plans to highlight collective actions within all jurisdictions, as well as an update of the recent data. This is being done in light of acquiring data as the process can help inform and identify actions in order to support change. Therefore, these factors are responsible for considerably propelling market growth in Canada.

COMPETITIVE INSIGHTS

Districlass Medical, Endalis, Appolo Endosurgery Inc, Aspire Bariatrics, Helioscopie SA, Spatz FGIA, etc. are some of the prominent market players.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32317

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET OVERVIEW

  • 3.1. OBESITY
  • 3.2. BMI RANGES
  • 3.3. MORBID OBESITY
  • 3.4. LOSING WEIGHT
  • 3.5. HISTORY OF INTRAGASTRIC BALLOON
  • 3.6. RE-ENTRY OF INTRAGASTRIC BALLOON
  • 3.7. ADVANTAGES OF INTRAGASTRIC BALLOON
  • 3.8. COMPLICATIONS ASSOCIATED WITH INTRAGASTRIC BALLOON
  • 3.9. WHO IS NOT SUITABLE FOR PLACEMENT OF INTRAGASTRIC BALLOON?

4. MARKET DYNAMICS

  • 4.1. MARKET DEFINITION
  • 4.2. KEY DRIVERS
    • 4.2.1. HUGE OBESE POPULATION
    • 4.2.2. RISE IN GOVERNMENT INITIATIVES
    • 4.2.3. UNHEALTHY LIFESTYLE
    • 4.2.4. SHORT HOSPITAL STAY AND SHORT RECOVERY TIME POST-INTRAGASTRIC BALLOONING
  • 4.3. KEY RESTRAINTS
    • 4.3.1. STRINGENT PRODUCT APPROVAL
    • 4.3.2. SHORT-TERM EFFECTS OF INTRAGASTRIC BALLOONING FOR WEIGHT LOSS
    • 4.3.3. ADVERSE EVENTS OF INTRAGASTRIC BALLOON
    • 4.3.4. LACK OF REIMBURSEMENT FOR INTRAGASTRIC BALLOONING

5. KEY ANALYTICS

  • 5.1. PORTER'S FIVE FORCE ANALYSIS
    • 5.1.1. THREAT OF NEW ENTRY
    • 5.1.2. THREAT OF SUBSTITUTION
    • 5.1.3. BUYER'S POWER
    • 5.1.4. SUPPLIER'S POWER
    • 5.1.5. COMPETITIVE RIVALRY
  • 5.2. IMPACT OF COVID-19 ON INTRAGASTRIC BALLOON IMPLANT
  • 5.3. VALUE CHAIN ANALYSIS
  • 5.4. SUPPLY CHAIN ANALYSIS
  • 5.5. OPPORTUNITY MATRIX
  • 5.6. VENDOR LANDSCAPE
  • 5.7. KEY INVESTMENT INSIGHT

6. MARKET BY PRODUCT

  • 6.1. SINGLE BALLOON
  • 6.2. DUAL BALLOON
  • 6.3. TRIPLE BALLOON

7. MARKET BY FILLING MATERIAL

  • 7.1. SALINE-FILLED
  • 7.2. GAS-FILLED

8. MARKET BY END-USE

  • 8.1. CLINICS
  • 8.2. HOSPITALS
  • 8.3. AMBULATORY SURGICAL CENTERS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA

10. COMPANY PROFILE

  • 10.1. APOLLO ENDOSURGERY INC
  • 10.2. ASPIRE BARIATRICS INC
  • 10.3. ALLURION TECHNOLOGIES INC
  • 10.4. ALLERGAN INC
  • 10.5. BARONOVA INC
  • 10.6. DISTRICLASS MEDICAL
  • 10.7. ENDALIS
  • 10.8. HELIOSCOPIE SA
  • 10.9. MEDSIL
  • 10.10. OBALON THERAPEUTICS INC
  • 10.11. RESHAPE LIFESCIENCES
  • 10.12. SILIMED INC
  • 10.13. SPATZ FGIA

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - INTRAGASTRIC BALLOON
  • TABLE 2: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY PRODUCT, HISTORICAL YEAR, 2016-2019 (IN $ MILLION)
  • TABLE 3: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY FILLING MATERIAL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY FILLING MATERIAL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY END-USE, HISTORICAL YEARS, 2016-2019, (IN $ MILLION)
  • TABLE 7: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY END-USE, FORECAST YEARS, 2019-2028, (IN $ MILLION)
  • TABLE 8: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY PRODUCT, IN 2019
  • FIGURE 5: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY SINGLE BALLOON, 2019-2028 (IN $ MILLION)
  • FIGURE 6: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY DUAL BALLOON, 2019-2028 (IN $ MILLION)
  • FIGURE 7: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY TRIPLE BALLOON, 2019-2028 (IN $ MILLION)
  • FIGURE 8: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY FILLING MATERIAL, IN 2019
  • FIGURE 9: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY SALINE-FILLED, 2019-2028 (IN $ MILLION)
  • FIGURE 10: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY GAS-FILLED, 2019-2028 (IN $ MILLION)
  • FIGURE 11: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY END-USE, IN 2019
  • FIGURE 12: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY CLINICS, 2019-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY HOSPITALS, 2019-2028 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY AMBULATORY SURGICAL CENTERS, 2019-2028 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA INTRAGASTRIC BALLOON MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 16: THE UNITED STATES INTRAGASTRIC BALLOON MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 17: CANADA INTRAGASTRIC BALLOON MARKET, 2019-2028 (IN $ MILLION)
Back to Top